✦ 24h Briefing Top Stories World U.S.India Business Technology Science Health Sports Entertainment

Loading

Fetching the latest headlines…

NabkaNews aggregates headlines from thousands of publishers worldwide via Google News, and provides AI-generated summaries and briefings for convenience. Every story links to its original source. We do not host or claim ownership of third-party reporting, and AI summaries may contain errors — always verify with the original source.

24h Briefing Top Stories World U.S.India Business Technology Science Health Sports Entertainment

Disclaimer Privacy Policy Terms of Use

© 2026 NabkaNews · World · U.S. · India — updated continuously. NabkaNews is an independent news aggregator and is not affiliated with any publisher shown.

GLP-1 Dementia Risk: Hype or Hope? · NabkaNews

← Back to headlines

GLP-1 Dementia Risk: Hype or Hope?

Diabetes In Control·Jan 9

This story is reported by Diabetes In Control. Read what other outlets are saying below, then open the original report for full details.

Full coverage

Opinion | GLP-1s can’t cure everything after all

The Washington Post·Dec 16

GLP-1 Alcohol Use Reduction: Can It Really Help?

Diabetes In Control·Jan 9

The good, bad and ugly of GLP-1 weight-loss drugs: Ozempic scams, celebrity hype and nasty side effects

Sunday Tribune·May 31

Scientists find Ozempic may treat cancer, Alzheimer's and more. Is it hype or truly a "wonder drug?"

Salon.com·Jan 24

Human gut microbiome: Therapeutic opportunities for metabolic syndrome—Hype or hope?

Wiley Online Library·Sep 28

The false hope of the new Alzheimer’s drugs The NHS was right to reject them

View original report at Diabetes In Control ↗